1Biernaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept [ J ].Cardiovasc Res, 1998,37(3 ) :586 - 600.
2Castellani R J, Harris PLR, Sayre LM, et al. Active glycation in neurofibrillary pathology of Alzheimer＇ s disease: Nε-( Carboxymethyl )lysine and hexitol-lysine [ J]. Free Rad Biol Med, 2001,31(2) :175 - 180.
3Wagle D, Vasan S, Egan JJ. Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging [ P]. WO: 01/52847, 2001-01-19.
4Avendano GF, Agarwal RK, Bashey RI et al. Effects of glucose intolerance on myocardial function and collagenlinked glycation [ J ]. Diabetes, 1999,48 ( 7 ): 1443 -1447.
5Imanaga Y, Sakata N, Takebayashi S, et al. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human athersclerotic plaques [ J ].Atherosclerosis, 2000,150 (2) :343 - 355.
6Gilbert RE, Kelly DJ, Alkins RC. Novel approaches to the treatment of progressive renal disease [ J ]. Curr Opinion Pharmacol, 2001,1(2) :183 - 189.
7Ulrich P, Cerami A. Protein glycation, diabetes, and aging [J]. Recent Prog Horm Res, 2001,56:1 -21.
8Cerami A, Ulrich P. Pharmaceutical intervention of advanced glycation endproducts [ J ]. Novartis Found Symp, 2001,235:202 - 212.
